TL;DR: Aetna, a CVS Health company, modified CPB 0248 governing FEES, FEESST, and MBSS swallowing evaluations, effective September 26, 2025. Billing teams should audit charge capture for CPT codes 92612–92617, 92610, 92611, 74230, and 92526 before that date.


Aetna updated its FEES and FEESST coverage policy under CPB 0248 Aetna system, now providing explicit criteria for when fiberoptic endoscopic evaluation of swallowing is the preferred test over videofluoroscopy. This distinction matters for reimbursement because it directly shapes how you document medical necessity on claims. The policy covers CPT codes 92612, 92613, 92614, 92615, 92616, and 92617 for endoscopic evaluations, plus 92610, 92611, and 74230 for fluoroscopic and oral pharyngeal assessments—and it lays out specific clinical conditions that determine which test Aetna will pay for. Get your billing team aligned on these criteria before the September 26, 2025 effective date.


Quick-Reference Table

Field Detail
Payer Aetna, a CVS Health company
Policy Fiberoptic Endoscopic Evaluation of Swallowing (FEES)/FEESST and Laryngopharyngeal Endoscopic Esthesiometer (LPEER)
Policy Code CPB 0248
Change Type Modified
Effective Date September 26, 2025
Impact Level High
Specialties Affected Speech-Language Pathology, Otolaryngology, Neurology, Radiology, Gastroenterology, Pulmonology, ICU/Critical Care
Key Action Map clinical documentation to Aetna's 10 FEES-preferred criteria and update charge capture for CPT 92612–92617 before September 26, 2025

Aetna FEES and FEESST Coverage Criteria and Medical Necessity Requirements 2025

The updated Aetna FEES coverage policy does something useful: it draws a clear line between when FEES is merely acceptable and when it's the preferred test. That's not a small distinction. Payers use preference language to justify denials when they believe a cheaper or simpler test would have done the job.

Aetna considers both fiberoptic endoscopy and videofluoroscopy medically necessary for evaluating swallowing function. But the policy now enumerates 10 specific clinical conditions where FEES—billed under CPT 92612 and 92613 for the procedure and physician interpretation—takes priority over videofluoroscopy.

The 10 FEES-Preferred Conditions

Aetna will recognize FEES (CPT 92612, 92613) as the preferred test over videofluoroscopy in any of the following situations:

#Covered Indication
1Aspiration risk from barium — When a more conservative exam is required due to concerns about aspiration of barium, food, or liquid.
2Fatigue or meal-length assessment — When you need to assess fatigue or swallowing status over the course of a full meal.
3Repeat examination — To track change over time, assess maneuver effectiveness, or determine whether maneuvers are still needed.
+ 7 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

The real issue here is documentation. Any claim for CPT 92612 or 92613 on an Aetna member should have a clear clinical note that maps to one or more of these 10 conditions. A generic dysphagia diagnosis code alone—even a valid one like R13.10—won't protect you from a claim denial if the record doesn't explain why FEES was preferred over videofluoroscopy.

FEESST and Sensory Testing (CPT 92614–92617)

The FEESST sensory testing component—endoscopic air pulse stimulation—is covered under CPT 92614 and 92615 (sensory testing, procedure and physician interpretation) and CPT 92616 and 92617 (combined FEES and sensory testing, procedure and physician interpretation). Coverage requires that the patient has persistent dysphagia and meets the FEES criteria above. You can't bill the sensory component as a standalone path around the base FEES criteria.

Modified Barium Swallow Study (CPT 74230, 92610, 92611)

The MBSS coverage policy runs parallel to FEES. Aetna covers the modified barium swallow study—billed as CPT 74230, 92610, or 92611—when it's performed by a speech-language pathologist and radiologist together, dysphagia has already been diagnosed, and at least one of these conditions applies:

#Covered Indication
1Clinical swallow evaluation shows aspiration risk
2Follow-up of a known swallowing disorder
3Need to determine appropriate diet level or liquid consistency
+ 1 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

This is worth noting for practices that bill MBSS and FEES together or in sequence. Aetna's policy covers both modalities—but each requires its own documented medical necessity basis.

Prior Authorization

The policy doesn't specify a blanket prior authorization requirement for these codes, but prior auth requirements vary by plan. Check Aetna member-specific plan details before scheduling. Post-intubation cases and ICU patients in particular may trigger utilization management review. If you're not sure what applies to your patient mix, talk to your compliance officer before the September 26, 2025 effective date.


Aetna FEES and FEESST Exclusions and Non-Covered Indications

The Laryngopharyngeal Endoscopic Esthesiometer (LPEER) appears in the policy title but is not listed in the covered criteria or the code table. The policy title names it; the clinical criteria and billing guidelines don't support it as a separately billable service under CPB 0248. Don't bill for LPEER as a distinct service under this policy. If you're using LPEER technology as part of a FEESST procedure, it falls under the FEESST framework—not as an independent covered service.

There are no separate experimental or investigational designations listed for the covered CPT codes in this policy update. If Aetna considers a specific application experimental, it would appear in a separate technology assessment. Nothing in CPB 0248 as modified designates 92612–92617 or related codes as experimental.


Coverage Indications at a Glance

Indication Status Relevant Codes Notes
FEES for evaluation of swallowing function (general) Covered 92612, 92613 Must meet at least one of 10 FEES-preferred criteria
FEES preferred over videofluoroscopy — aspiration risk from barium Covered / Preferred 92612, 92613 Document barium aspiration concern in clinical notes
FEES preferred — fatigue or meal-length assessment Covered / Preferred 92612, 92613 Document need to assess full-meal swallowing status
+ 16 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

This policy is now in effect (since 2025-09-26). Verify your claims match the updated criteria above.

Aetna FEES and FEESST Billing Guidelines and Action Items 2025

These are the specific steps your billing team should take before the September 26, 2025 effective date.

#Action Item
1

Audit your charge capture for CPT 92612–92617 on all Aetna claims. Pull the last 90 days of claims for these codes and check whether the corresponding clinical documentation maps to one of Aetna's 10 FEES-preferred criteria. If it doesn't, you have a denial risk starting September 26, 2025.

2

Update clinical documentation templates for FEES cases. Work with your SLP and ENT teams to build a structured note field that explicitly addresses the applicable FEES-preferred condition. "Patient is tube-fed and has severely impaired swallow reflex consistent with brainstem stroke" is defensible. "FEES performed for dysphagia evaluation" is not—at least not alone.

3

Separate FEESST billing into component codes when appropriate. If you're performing combined FEES and sensory testing, bill CPT 92616 and 92617 (combined procedure and interpretation). If you're billing sensory testing separately, use 92614 and 92615. Make sure the claim reflects what was actually performed and that the documentation supports persistent dysphagia plus FEES criteria.

+ 4 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for FEES and FEESST Under CPB 0248

Covered CPT Codes (When Selection Criteria Are Met)

Code Type Description
74230 CPT Swallowing function, with cineradiography/videoradiography (including modified barium swallowing study)
92610 CPT Evaluation of oral and pharyngeal swallowing function
92611 CPT Motion fluoroscopic evaluation of swallowing function by cine or video recording
+ 6 more codes

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Key ICD-10-CM Diagnosis Codes

Code Description
G45.0–G45.9 Transient cerebral ischemic attack (multiple subcategory codes)
I65.01–I67.9 Occlusion and stenosis of precerebral arteries, occlusion of cerebral arteries, and acute but ill-defined cerebrovascular disease
I69.091 Dysphagia following unspecified cerebrovascular disease
+ 17 more codes

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Get the Full Picture for CPT 92612

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee